Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 2115
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
generactor
08/20/2025 11:18:06 PM
Fantastic interview.
(21)
USS JOHNSTON
08/20/2025 11:12:40 PM
Excellent video! Some highlights after
(31)
twinter11
08/20/2025 9:29:59 PM
Dr. Jacob Lalezari, MD - CEO, CytoDyn -
(38)
MJS719
08/20/2025 7:49:08 PM
Interesting tidbit that I have no idea
(1)
sean007
08/20/2025 1:07:23 PM
IF we take last years date,...It is a
(4)
sean007
08/20/2025 12:42:06 PM
The window for asking for additional
(16)
brentie
08/20/2025 12:27:25 PM
In 2021 they had the meeting on
(9)
Katangolo
08/20/2025 11:51:02 AM
???? Core evidence of the unnamed tech
(27)
biloxiblues
08/20/2025 11:26:47 AM
Trying to solve the puzzle. With AI The
(18)
Katangolo
08/20/2025 11:07:32 AM
Here it is 9/30/2020
(8)
Katangolo
08/20/2025 11:05:35 AM
I just went on the CYDY website and
(9)
Katangolo
08/20/2025 10:06:19 AM
Wasnt manufacturing discussed a few
(19)
Katangolo
08/20/2025 9:57:56 AM
We had the annual meeting in September
(13)
My69z
08/20/2025 8:43:54 AM
Agree on pre-clinical affect & include
(18)
KenChowder
08/20/2025 8:28:16 AM
I was writing back and forth with
(28)
KenChowder
08/20/2025 6:29:10 AM
It doesn't have to take a long time for
(10)
docj
08/20/2025 6:17:29 AM
Thought I'd post this on IH since Ken
(12)
My69z
08/20/2025 3:42:11 AM
& Proxy is end of Nov..... You are
(8)
HouseofCards
08/19/2025 11:34:20 PM
I know we've heard rumors about quiet
(14)
My69z
08/19/2025 9:32:22 PM
Something big is going to develop
(6)
My69z
08/19/2025 5:09:25 PM
Feb. 6th, 2025: As the Company
(18)
Niele
08/19/2025 4:48:01 PM
It is my understanding that the S-3
(5)
USS JOHNSTON
08/19/2025 4:03:56 PM
Fly-on-the-Vancouver-wall Question:
(25)
misiu143
08/19/2025 3:13:33 PM
If dose will be change to 700 mg , all
(22)
HouseofCards
08/19/2025 2:37:54 PM
Something MGK and Ken were talking
(3)
Buddyboy20
08/19/2025 2:23:58 PM
I have read a little on SSAT and CCR5
(5)
Respert24
08/19/2025 1:51:36 PM
Its only a waste of time if you
(13)
dfwl28
08/19/2025 1:29:15 PM
Does LL positively impact enzyme SSAT?
(15)
Evil Rabbit
08/19/2025 12:43:30 PM
12 thumbs down. Thats impressive.
(10)
Evil Rabbit
08/19/2025 11:28:36 AM
Add the 30+ Ive deleted just this
(16)
waxonwaxoff
08/19/2025 11:23:26 AM
Have to agree. As much as I tried to
(10)
HHIGambler
08/19/2025 10:58:13 AM
My compassion ran out after I deleted
(11)
craigakess
08/19/2025 10:54:25 AM
The one thing I would say about Riz is
(9)
HHIGambler
08/19/2025 10:47:31 AM
He clearly has mental health issues. He
(11)
biloxiblues
08/19/2025 10:45:54 AM
Thank you to the Moderators. This
(8)
Evil Rabbit
08/19/2025 10:44:02 AM
Worst board member of all time and
(15)
HHIGambler
08/19/2025 10:40:22 AM
Can anyone with an ounce of sense
(11)
HHIGambler
08/19/2025 10:37:21 AM
You're reading 2-3 more words than me.
(11)
Evil Rabbit
08/19/2025 10:19:52 AM
MODS fingers must be blistered by
(13)
KenChowder
08/19/2025 7:23:45 AM
That's a good question, but we don't
(22)
My69z
08/19/2025 7:13:04 AM
Dec. 17th, 2024: If the RECOVER-TLC
(8)
MGK_2
08/19/2025 7:08:36 AM
I'd go along with that Ken, but tell me
(11)
KenChowder
08/19/2025 6:04:42 AM
MGK wrote: The two criteria that the
(25)
MGK_2
08/19/2025 5:05:16 AM
This is a more complete and concise
(11)
My69z
08/18/2025 9:59:11 PM
In progress: CRC 60 patient trial.
(11)
docj
08/18/2025 8:50:59 PM
I guess my initial reaction is... there
(11)
craigakess
08/18/2025 7:45:39 PM
Hey Riz. If I thought Leronlimab for
(10)
MGK_2
08/18/2025 7:23:36 PM
I provide this to give an idea of how
(28)
Buddyboy20
08/18/2025 6:54:00 PM
It seems like it was only a few days
(4)
waxonwaxoff
08/18/2025 3:16:52 PM
My first guess is either overly
(9)
Newer
Older
Recent Articles
Chevron Prepares to Announce Q3 Financial Results Soon
Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
China Leads the Way in Urban Health amidst Climate Challenges
Zoomlion's Vision for Sustainable Smart Cities Worldwide
Crédit Agricole S.A. Completes Share Repurchase Program Successfully
Fresnillo Makes Strategic Move to Acquire Probe Gold
Projected Growth of Genomics Data Analysis Market to 2034
Nanobiotix Secures Up to $71 Million in Innovative Funding
Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
Michael Burry's Caution: Avoiding Market Bubbles in 2025
Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
AB Artea Bankas Receives Updated Capital Requirements from ECB
Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
Bekaert's Share Buyback Program and Liquidity Actions Explained
Sidetrade Partners with NX to Enhance CFO Agility and Growth
Top Stock Performers: Insights on Major Market Movers
Facephi Shows Strong Financial Performance and Future Growth
Kalmar Reports Strong Q3 2025: Profitability and Success in Services
Loomis Achieves Remarkable Performance in Recent Quarter
Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
DXS International's Annual Report: Key Insights and Financials
Digitalist Group's Third Quarter Review Highlights 2025 Results
Strong Q3 Results Highlight Growth and Stability for WEHB
NB Private Equity Partners Effectively Executes Share Buyback
ICG Enterprise Trust plc Makes Strategic Share Buyback Move
Understanding the Voting Rights of Northern Venture Trust PLC
Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
Understanding Voting Rights at Northern 2 VCT PLC
Notable Growth for INVL Technology in 2025 Financials
Understanding the Latest Net Asset Value of INVL Technology
Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy